Lipid and Metabolic Syndromes

Metabolic syndrome is the major cause that contribute to cardiovascular morbidity and mortality. It is a cluster of metabolic disorders, such as dyslipidemia, abdominal obesity, hypertension and impaired fasting glucose which will increase the risk for cardiovascular disease. The dietary lipids are also recognized to contribute in the development and the prevention of cardiovascular risk clustering. This review explores the relevant mechanisms involved in the influence of dietary fatty acids on metabolic syndrome components.

The development of metabolic syndrome mainly due to Genetics and the environmental factors. Approximately 20%-30% of the population in industrialized countries has metabolic syndrome and the people with Metabolic syndrome will have three times higher risk of developing cardiovascular disease. Additionally, statin drugs play a key role in the treatment of people with coronary heart disease, mostly because they lower LDL cholesterol.

The treatment choices include changing lifestyle and weight reduction which usually requires a specifically tailored, multifaceted program that includes diet and exercise. Medications also may be useful.

  • High blood cholesterol
  • Diabetes
  • Stress and hypertension
  • Obesity and overweight
  • Smoking and alcohol
  • Physical inactivity
  • Heredity and gender
  • Age and sex hormones
  • Cardiovascular epidemiology

Related Conference of Lipid and Metabolic Syndromes

December 26-27, 2024

28th World Cardiology Conference

Paris, France
February 20-21, 2025

35th International Conference on Cardiology and Healthcare

Amsterdam, Netherlands
February 20-21, 2025

14th World Congress on Cardiology

Amsterdam, Netherlands
February 24-25, 2025

40th World Cardiology Conference

London, UK
February 24-25, 2025

33rd International Conference on Cardiology and Cardiovascular Diseases

London, UK
February 27-28, 2025

4th Global Summit on Cardiology and Cardiac Surgery

Paris, France
March 24-25, 2025

14th World Heart Congress

Paris, France
April 16-17, 2025

8th World Heart and Brain Conference

Tokyo, Japan
April 23-24, 2025

14th International Conference on Cardiology and Cardiovascular Medicine Research

Paris, France
April 24-25, 2025

9th Annual Heart Rhythm Conference

Vienna, Austria
April 28-29, 2025

37th World Congress on Cardiology & Heart Diseases

Frankfurt, Germany
April 28-29, 2025

39th World Congress on Heart Diseases

Frankfurt, Germany
May 14-15, 2025

6th International Conference on Cardiac Imaging and Diagnostics

Barcelona, Spain
May 19-20, 2025

4th International Conference on Cardiology

Rome, Italy
May 22-23, 2025

5th World Congress on Congestive Heart Failure & Angina

Zurich, Switzerland
May 26-27, 2025

6th European Summit on Cardiology Research

Rome, Italy
June 12-13, 2025

12th International Conference on Interventional Cardiology

London, UK
June 19-20, 2025

12th World Congress on Hypertension, Cardiology, Primary Health and Patient Care

Paris, France
July 21-22, 2025

33rd International Congress on Cardiology and Medical Interventions

Toronto, Canada
July 24-25, 2025

8th International Conference on Cardiovascular Diseases and Therapeutics

Aix-en-Provence, France
August 11-12, 2025

3rd International Conference on World Heart Care

Toronto, Canada
August 21-22, 2025

8th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada
August 21-22, 2025

34th International Conference on Clinical and Experimental Cardiology Research

Vancouver, Canada
September 08-09, 2025

39th European Cardiology Conference

Frankfurt, Germany
September 22-23, 2025

7th Annual Conference on Vascular Medicine

Amsterdam, Netherlands
October 20-21, 2025

36th International Conference on Cardiology and Heart Failure

Osaka, Japan
October 22-23, 2025

12th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

Paris, France

Lipid and Metabolic Syndromes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in